When to worry about ALT levels in pregnancy?

ALT levels above 40 U/L during pregnancy may indicate liver complications like HELLP syndrome, intrahepatic cholestasis, or acute fatty liver. Seek immediate medical attention for levels over 100 U/L or if accompanied by symptoms like severe itching, upper abdominal pain, or jaundice.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding ALT and Its Role During Pregnancy

Alanine aminotransferase (ALT) is an enzyme primarily found in liver cells that helps convert proteins into energy. During pregnancy, monitoring ALT levels becomes particularly important as they can indicate how well your liver is functioning while supporting both you and your growing baby. Normal ALT levels typically range from 7-35 U/L for women, though some laboratories use slightly different reference ranges.

Pregnancy places additional demands on your liver, which must process increased blood volume, hormones, and metabolic byproducts. While mild fluctuations in liver enzymes can be normal, significant elevations in ALT may signal serious pregnancy-related liver conditions that require immediate medical attention. Understanding when ALT levels become concerning can help ensure both maternal and fetal health throughout pregnancy.

Normal vs. Concerning ALT Levels in Pregnancy

During pregnancy, ALT levels generally remain within the normal range or may even decrease slightly due to hemodilution from increased blood volume. However, certain thresholds indicate when medical evaluation becomes necessary. Understanding these ranges helps distinguish between normal variations and potentially serious conditions.

ALT Level Categories During Pregnancy

These ranges are general guidelines. Always consult your healthcare provider for interpretation based on your specific situation.
ALT Level (U/L)CategoryClinical SignificanceAction Required
7-357-35 U/LNormalHealthy liver functionContinue routine prenatal care
36-7036-70 U/LMildly ElevatedMay indicate early liver stressRepeat testing, monitor symptoms
71-20071-200 U/LModerately ElevatedSuggests active liver diseaseUrgent evaluation needed
Above 200>200 U/LSeverely ElevatedIndicates serious liver dysfunctionImmediate hospitalization

These ranges are general guidelines. Always consult your healthcare provider for interpretation based on your specific situation.

When ALT Levels Require Immediate Attention

You should contact your healthcare provider immediately if your ALT levels exceed 40 U/L, especially if accompanied by symptoms. Levels above 100 U/L are particularly concerning and may indicate acute liver dysfunction. Very high levels (above 500 U/L) are medical emergencies requiring immediate hospitalization and evaluation.

The timing of ALT elevation during pregnancy also matters. First-trimester elevations might suggest pre-existing liver disease or hyperemesis gravidarum, while third-trimester elevations often point to pregnancy-specific conditions like preeclampsia or HELLP syndrome. Regular monitoring through comprehensive blood testing can help detect these changes early.

Common Causes of Elevated ALT in Pregnancy

Pregnancy-Specific Liver Conditions

Several liver conditions unique to pregnancy can cause ALT elevation. HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelets) typically occurs in the third trimester and represents a severe form of preeclampsia. This condition requires immediate delivery and can be life-threatening if left untreated. ALT levels in HELLP syndrome often range from 100-1000 U/L.

Intrahepatic cholestasis of pregnancy (ICP) is another common cause, affecting 1-2% of pregnancies. This condition typically presents with intense itching, particularly on the palms and soles, and mild to moderate ALT elevation (usually 2-10 times normal). While less immediately dangerous than HELLP, ICP increases the risk of preterm birth and stillbirth, requiring close monitoring and often early delivery.

Acute fatty liver of pregnancy (AFLP) is rare but serious, occurring in about 1 in 10,000 pregnancies. It typically presents in the third trimester with nausea, vomiting, abdominal pain, and jaundice. ALT levels are usually moderately elevated (200-500 U/L), and the condition requires immediate delivery to prevent maternal and fetal mortality.

Pre-existing liver conditions can worsen during pregnancy due to increased metabolic demands. These include viral hepatitis (particularly hepatitis B and C), autoimmune hepatitis, and non-alcoholic fatty liver disease. Gallstones, more common during pregnancy due to hormonal changes, can also cause ALT elevation if they obstruct bile flow.

Certain medications commonly used during pregnancy may elevate ALT levels. These include acetaminophen (when used excessively), some antibiotics, and antiepileptic drugs. Always inform your healthcare provider about all medications and supplements you're taking during pregnancy.

Symptoms That Accompany Concerning ALT Levels

While elevated ALT itself doesn't cause symptoms, the underlying conditions causing the elevation often do. Recognizing these symptoms can help you seek timely medical care and potentially prevent serious complications.

  • Severe, persistent itching, especially on palms and soles (may indicate ICP)
  • Upper right abdominal pain or epigastric pain
  • Nausea and vomiting beyond typical morning sickness
  • Jaundice (yellowing of skin and eyes)
  • Dark urine and pale stools
  • Sudden weight gain and swelling (edema)
  • Severe headaches or visual changes
  • Extreme fatigue or malaise
  • Easy bruising or bleeding

The combination of symptoms with elevated ALT levels often provides crucial diagnostic clues. For instance, severe itching with mild ALT elevation suggests ICP, while upper abdominal pain with very high ALT levels might indicate HELLP syndrome. Any of these symptoms warrant immediate medical evaluation.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Diagnostic Tests and Monitoring

When ALT levels are elevated during pregnancy, your healthcare provider will typically order a comprehensive metabolic panel to assess overall liver function. This includes other liver enzymes (AST, alkaline phosphatase, GGT), bilirubin levels, and markers of liver synthetic function like albumin and prothrombin time.

Additional Testing for Elevated ALT

Beyond basic liver function tests, your provider may order specific tests based on suspected conditions. For ICP, bile acid levels are the most sensitive diagnostic test. For HELLP syndrome, a complete blood count will show low platelets and evidence of hemolysis. Viral hepatitis panels, autoimmune markers, and ultrasound imaging may also be necessary.

The frequency of monitoring depends on the severity of ALT elevation and suspected diagnosis. Mild elevations might require weekly monitoring, while severe elevations or concerning symptoms may necessitate daily testing or continuous inpatient monitoring. Regular testing helps track disease progression and guide treatment decisions.

For those interested in proactive health monitoring during pregnancy, comprehensive metabolic testing can provide valuable insights into liver function and overall health status. Understanding your baseline values early in pregnancy makes it easier to detect significant changes.

Treatment and Management Options

Treatment for elevated ALT during pregnancy depends entirely on the underlying cause. For pregnancy-specific conditions, delivery is often the definitive treatment, though the timing depends on gestational age and severity of maternal and fetal compromise.

Medical Interventions

For ICP, ursodeoxycholic acid (UDCA) is the primary treatment, helping to reduce bile acid levels and improve symptoms. Close fetal monitoring and early delivery (typically at 37 weeks) are standard protocols. HELLP syndrome and AFLP require immediate hospitalization, blood pressure control, seizure prevention with magnesium sulfate, and expedited delivery regardless of gestational age.

Supportive care measures include intravenous fluids, nutritional support, and careful monitoring of both mother and baby. In severe cases, blood product transfusions or even liver transplantation may be necessary, though this is extremely rare.

Lifestyle Modifications

While medical treatment is primary for serious liver conditions in pregnancy, certain lifestyle modifications can support liver health:

  • Maintain adequate hydration
  • Eat small, frequent meals to reduce nausea
  • Avoid foods high in fat if experiencing nausea or upper abdominal pain
  • Get adequate rest and sleep on your left side to improve blood flow
  • Avoid alcohol completely and limit acetaminophen use
  • Take prenatal vitamins as directed
  • Engage in gentle exercise as approved by your provider

Long-term Implications and Follow-up

Most pregnancy-related liver conditions resolve after delivery, with ALT levels typically normalizing within days to weeks. However, some conditions have long-term implications. Women who develop HELLP syndrome or preeclampsia have increased cardiovascular risk later in life. Those with ICP have a higher risk of developing gallstones and may experience recurrence in subsequent pregnancies.

Post-pregnancy monitoring is essential to ensure complete resolution of liver dysfunction. Your provider will likely check liver enzymes at your postpartum visit and may recommend periodic monitoring thereafter. Women with persistent ALT elevation after delivery require further evaluation for underlying chronic liver disease.

For future pregnancies, having a history of liver complications means you'll need closer monitoring from the start. Baseline liver function tests in early pregnancy and regular monitoring throughout can help detect problems early. Some women may benefit from prophylactic treatments or modified delivery timing based on their history.

Taking Control of Your Liver Health During Pregnancy

Understanding ALT levels and their significance during pregnancy empowers you to advocate for your health and recognize when to seek medical attention. While elevated ALT can signal serious conditions, prompt recognition and treatment lead to excellent outcomes for most women and their babies.

Remember that any concerning symptoms or laboratory abnormalities during pregnancy warrant immediate medical evaluation. Don't hesitate to contact your healthcare provider if you experience severe itching, upper abdominal pain, or other symptoms mentioned in this article. Early detection and treatment of liver conditions in pregnancy can prevent serious complications and ensure the best possible outcome for both mother and baby.

If you have existing blood test results showing your ALT levels or other liver enzymes, you can get a comprehensive analysis of what they mean for your health. Upload your results to SiPhox Health's free blood test analysis service for personalized insights and recommendations tailored to your unique health profile. This AI-driven tool can help you better understand your liver function and track changes over time, empowering you to take control of your health journey.

References

  1. Ch'ng CL, Morgan M, Hainsworth I, Kingham JG. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut. 2002;51(6):876-880.[Link][PubMed]
  2. Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol. 2016;64(4):933-945.[Link][PubMed][DOI]
  3. Lee NM, Brady CW. Liver disease in pregnancy. World J Gastroenterol. 2009;15(8):897-906.[Link][PubMed][DOI]
  4. Guntupalli SR, Steingrub J. Hepatic disease and pregnancy: an overview of diagnosis and management. Crit Care Med. 2005;33(10 Suppl):S332-339.[PubMed][DOI]
  5. Hay JE. Liver disease in pregnancy. Hepatology. 2008;47(3):1067-1076.[Link][PubMed][DOI]
  6. Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA. Liver disease in pregnancy. Lancet. 2010;375(9714):594-605.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my ALT levels at home?

You can test your ALT levels at home with SiPhox Health's Heart & Metabolic Program. This CLIA-certified program includes ALT testing along with comprehensive liver and metabolic markers, providing lab-quality results from the comfort of your home.

What is the normal ALT range during pregnancy?

Normal ALT levels during pregnancy typically range from 7-35 U/L, though they may be slightly lower than pre-pregnancy levels due to increased blood volume. Any elevation above 40 U/L warrants medical evaluation, especially if accompanied by symptoms.

Can elevated ALT levels harm my baby?

Elevated ALT itself doesn't directly harm the baby, but the underlying conditions causing the elevation can. Conditions like HELLP syndrome, ICP, and acute fatty liver of pregnancy can lead to preterm birth, growth restriction, or stillbirth if left untreated, making prompt medical attention essential.

How quickly do ALT levels return to normal after delivery?

Most pregnancy-related liver conditions resolve rapidly after delivery, with ALT levels typically normalizing within 2-4 weeks. However, the exact timeline depends on the underlying cause and severity. Your doctor will monitor your levels postpartum to ensure complete resolution.

Should I avoid certain foods if my ALT is elevated during pregnancy?

While specific dietary restrictions depend on the underlying cause, generally avoiding high-fat foods can help if you're experiencing nausea or upper abdominal pain. Stay hydrated, eat small frequent meals, and completely avoid alcohol. Always follow your healthcare provider's specific dietary recommendations.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details